This week, the Joint Committee on Vaccination and Immunisation (JCVI), which sets the UK’s vaccine policies, recommended that 16 and 17-year-olds be offered the Pfizer vaccine – leading to speculation that the jab could soon be offered to even younger age groups. Speaking at a press conference on the issue yesterday, the deputy chief medical officer, Jonathan Van-Tam, said his sense was that it is ‘more likely rather than less likely’ that the list of children eligible for the vaccine would broaden.
It’s an interesting development given that just a fortnight ago the JCVI recommended against vaccinating over-12s unless they were particularly vulnerable to the disease. So Mr S was intrigued to hear that the Nottingham Trent Professor Robert Dingwall had been asked to leave his role advising the government on the JCVI Covid-19 sub-committee.
Dingwall has been outspoken on the topic of child vaccination in the past.
Comments
Join the debate for just $5 for 3 months
Be part of the conversation with other Spectator readers by getting your first three months for $5.
UNLOCK ACCESS Just $5 for 3 monthsAlready a subscriber? Log in